drugset / Trial / NCT00863941
A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
To compare the rate and extent of absorption of Abrika Bupropion 150 mg XL Tablet to that of Wellbutrin XL® 150 mg Tablet after a single, one-tablet dose in fasted subjects.
Timeline
- Start
- 2004-06
- Primary completion
- 2004-07
- Completion
- 2004-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 150 mg | — |
Indications
No indication recorded.